Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.5K citations · Full text

Medicine, Oncology, Pharmacology +15

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

Alfred H. Schinkel, Jasper Smit, Olaf van Tellingen et al. · Cell · 1994 · 2.3K citations

Medicine, Pharmacokinetics, Pharmacology +14

Structural alterations of the epidermal growth factor receptor gene in human gliomas.

Albert J. Wong, J. Michael Ruppert, Sandra H. Bigner et al. · Proceedings of the National Academy of Sciences · 1992 · 858 citations

Medicine, Genetics, Oncology +6

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Jeremy N. Rich, David A. Reardon, Terry Peery et al. · Journal of Clinical Oncology · 2003 · 736 citations · Full text

Medicine, Oncology, Pharmacology +17

Overexpression of the EGF Receptor and <i>p53</i> Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas

Kunihiko Watanabe, Osamu Tachibana, Kazufumi Sato et al. · Brain Pathology · 1996 · 734 citations · Full text

Medicine, Genetics, Oncology +17